[The seroepidemiology of the varicella-zoster virus in children and adolescents].
OBJECTIVE
To know the sero-protection level existing of varicella-zoster virus in a population of children and adolescents from Madrid.


METHODS
To carry out this work we have had a total 560 serum from children and adolescents between 1 and 15 years old. Later to detect the title of antibodies against the varicella zoster virus (IgG VZV), we used enzymo immuno-analysis (PLATEST).


RESULTS
The 96.5% of them were positive. Distributing this percentage in a similar way for every age, we get 100% at 8, 9, 10, 11 and 15 years old; 97.5% at 5, 6, 7, 12 and 13 years; 95% at 14 years old; 92.5% at 4 years old and 85% at 1 years old and 84% at 2 years old.


CONCLUSIONS
The prevalence gradually increases with the age, from 20% at 1 year old to 100% at 15, finding the smallest prevalence in 84% to reach rapidly 100%.
Gil Miguel
A
A
Departamento de Medicina Preventiva, Facultad de Medicina, Universidad Autónoma de Madrid.
Lasheras Lozano
M L
ML
Jiménez García
R
R
Calle Purón
M E
ME
Santos Santos
M
M
Rey Calero
J
J
Martín Hernández
D
D
D000293:Adolescent; D000367:Age Factors; D000914:Antibodies, Viral / Q000097:blood; D002644:Chickenpox / Q000453:epidemiology* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D007223:Infant; D015995:Prevalence; D016036:Seroepidemiologic Studies; D014505:Urban Population / Q000706:statistics & numerical data
D000914:Antibodies, Viral